Five Prime Therapeutics

Cureline is a global contract research organization (CRO) specializing in human biospecimen services, including biobanking and laboratory analysis, to support accelerated drug research and development since its inception in 2003. With a robust global clinical network and regulatory expertise, Cureline offers a diverse array of high-quality biospecimens and custom protocols tailored for various therapeutic areas, including oncology, infectious diseases, and neurological disorders. The company operates an extensive HBS biorepository located in the San Francisco Bay area, providing validated human biospecimens for biomarker development and translational research. Cureline has collaborated with over 150 clinical sites worldwide and has successfully completed projects for approximately 700 clients while actively participating in significant NIH scientific consortiums. Generated from the website

Pionyr Immunotherapeutics, Inc., a biotechnology company based in South San Francisco, CA, was acquired by Ikena Oncology, Inc. in August 2023. Their innovative Myeloid Tuning programs aim to enhance the immune system's anti-tumor response by modifying the cellular infiltrate of the tumor microenvironment. With clinical programs targeting TREM2 and TREM1, Pionyr focuses on selectively depleting and reprogramming tumor-associated macrophages responsible for immunosuppression, demonstrating safety in Phase 1a b trials alone and in combination with pembrolizumab. Additionally, their IND-ready program, PY265 anti-MARCO, aims to activate the immune system in the tumor microenvironment. Pionyr Immunotherapeutics has made significant contributions to the field of immunotherapy, as evidenced by their posters, publications, and whitepapers. As part of Ikena Oncology, the company's business development team is open to discussions regarding licensing and partnerships for their pioneering programs. With a commitment to advancing cancer treatment, Pionyr Immunotherapeutics continues to make strides in developing novel therapies to combat tumors and improve patient outcomes.Generated from the website

Structure Therapeutics Inc is a biotechnology company based in South San Francisco, CA, focused on innovative therapeutic approaches. The company is dedicated to advancing its pipeline of drug candidates aimed at addressing unmet medical needs. With a team of experienced professionals, Structure Therapeutics emphasizes collaboration and cutting-edge research in the development of its therapies. Their commitment to scientific excellence drives their mission to improve patient outcomes through novel treatments. Generated from the website